Loading, Please Wait...
VAUDREUIL-DORION, QUEBEC--(Marketwired - Feb 25, 2016) - Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"), announced that their flagship product, Immunocal®, and Immunocal Platinum® have been certified by the world-class anti-doping lab, LGC, and now carry the INFORMED-CHOICE.ORG logo. LGC is a recognized quality-assurance program that ensures a supplement is tested for banned substances.
"This certification gives the Immunotec Consultants a significant advantage in the marketplace when combined with the recent performance claim granted by Health Canada," said Immunotec's Vice-President of Research & Development, John Molson. "This represents 'clean performance' in the truest sense of the word."
Immunotec has been collaborating with elite amateur and professional athletes in a wide array of sports since it was founded two decades ago. With the increased demand for Immunotec products due to the multitude of benefits experienced by both athletes and coaches, Immunotec took the steps to institute a testing program that would certify that all Immunocal and Immunocal Platinum products are systematically tested for banned substances. The certification "INFORMED-CHOICE" logo will now appear on all Immunocal and Immunocal Platinum packages.
Athletes at all levels, from amateur to Olympian, who rely on Immunocal and Immunocal Platinum will now be able to enter competition with an added peace of mind, knowing that the products being utilized are tested in one of the top quality-assurance programs worldwide. This reinforces our commitment to maintain the highest quality standards.
LGC is an international life sciences measurement and testing company, building leading positions in sustainably growing markets. Experts in regulation, accreditation and standard setting, they provide reference materials, genomics solutions and analytical testing products and services, stemming from their own innovations and intellectual property. LGC works with customers in the pharmaceuticals, agricultural biotechnology, food, environment, government, academic, security and sports sectors to achieve excellence in investigative, diagnostic and measurement science.
About Immunotec Inc.
Immunotec is a Canadian-based company that develops, manufactures, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the U.S., Mexico, Dominican Republic, United Kingdom and Ireland. The company offers an extensive line of nutritional, skin care and wellness products targeting health, weight management, energy and physical performance.
Please visit us at www.immunotec.com for additional information.
The company files its continuous disclosure documents, inclusive of its year end results, on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Vice-President of Research and Development
Patrick Montpetit, CPA: CA, CF
Vice-President and Chief Financial Officer